Industry

IRVING, Texas–(BUSINESS WIRE)–#teamvizient—Vizient, Inc. today released its latest Medical Device Tech Watch, identifying trends in artificial intelligence (AI), examining treatment options for pulmonary embolism and highlighting strategies to boost clinical workforce retention. The full Medical Device Tech Watch can be accessed here. “Advances in technology are having a positive impact not only on patient care … [Read more…]

– Primary Endpoint Met with 14.3% Reduction (p-value = 0.0064) in Mean Rate of Growth (Slope) in GA Area Over 12 Months Using Square Root Transformation; 17.7% Reduction (p-value = 0.0039) Using Observed GA Area – – Statistically Significant Result with Favorable Safety Profile – – Post-hoc Analysis of U.S. Patients: 25.5% Reduction (p-value = … [Read more…]

BEIJING–(BUSINESS WIRE)–#COVID19–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Chilean Public Health Institute (Instituto de Salud Pública, ISP) approved a phase II clinical trial for its inactivated Omicron strain COVID-19 vaccine and trivalent COVID-19 vaccine (ancestral, Delta and Omicron variants) on August 31st. … [Read more…]

TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#Artilysin–Lysando AG – market leader in the field of antimicrobial proteins – is pleased to announce that Fabian Geldmacher, M.D., has joined the team as Director Strategy & Business Development in June. Dr. Geldmacher will be responsible for shaping Lysando’s strategy and identifying areas where Lysando’s technology can add the most value. He … [Read more…]

Former Chief Financial Officer in numerous mid-caps and large international groups, with over 20 years’ professional experience in France and abroad. The expertise necessary to accelerate Valbiotis’ future hypergrowth in charge of the global financial strategy. A new appointment at a milestone in the Company’s history, in preparation for commercialization. LA ROCHELLE, France–(BUSINESS WIRE)–Regulatory News: … [Read more…]

Galderma, the pure-play dermatology category leader with a 40+ year heritage in dermatology, will present one oral, six symposia and four hub sessions demonstrating its scientific expertise and ongoing commitment to advancing dermatology 18 scientific and clinical posters will unveil new data on skin disease awareness and scientific innovation in prurigo nodularis, sensitive skin, acne, … [Read more…]

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that BTK inhibitor orelabrutinib has been granted priority review for the treatment of relapsed or refractory Marginal Zone Lymphoma (R/R MZL) by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA), … [Read more…]

Presentation of a new multi-biomarker panel with 95% accuracy for stage 1 to 3 ovarian cancer based on targeted mass spectrometry (MS) and bioinformatics Research results through Bertis’ technology platform were published as a cover article in the September issue of the international scientific journal, ‘Journal of Proteome Research’ SEONGNAM, South Korea–(BUSINESS WIRE)–#Bertis—Bertis, a proteomics-based … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–The approval obtained by the EIB is for a new credit facility of 40 million euros The new credit facility foresees that MedinCell repays in anticipation a previous 20 million euros loan signed in 2018 with the EIB 30 million euros of the credit facility could be drawn in Q4 2022, and the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “External Remote Patient Monitoring Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive information about the External Remote Patient Monitoring Devices pipeline products with comparative analysis of the products at various stages of … [Read more…]